Pharmaceutical composition for use in the therapeutic treatment of cancer and complications of cancer
OwnerGuy Faustin MONKAM NITCHEUinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to a pharmaceutical composition, characterised in that it comprises, as an active substance, a combination of beta-elemene, lupeol and a pharmaceutically active agent selected from cinnamaldehyde, 2-hydroxycinnamaldehyde, 2′- benzoyloxycinnamaldehyde, beta-sitosterol, curcumin and the mixtures thereof.
Claims10
1-10. (canceled).
A pharmaceutical composition, characterized in that it comprises, in combination, beta-elemene, lupeol, and/or beta-sitosterol, cinnamaldehyde and/or 2-hydroxycinnamaldehyde and/or 2′-benzoyloxycinnamaldehyde, and optionally curcumin.
The pharmaceutical composition as set forth in claim 10, for use in the therapeutic treatment of a cancer selected from among hepatocellular carcinoma, colon cancer, rectal cancer, stomach cancer, cancer of the mouth, particularly tongue cancer, prostate cancer, metastatic prostate cancer, kidney cancer, breast cancer, chemoresistant breast cancer, bladder cancer, leukemia in chronic or acute form, multiple myeloma, lymphoma, brain tumors, lung cancer, particularly lung adenocarcinoma, uterine cancer, ovarian cancer, bone tumors, pancreatic cancer, gall bladder cancer, and liver cancer.
A pharmaceutical preparation, characterized in that it comprises the composition according to the invention, and, in addition, as a mixture or packaged separately, at least one anti-cancer agent for use in the therapeutic treatment of cancer simultaneously, sequentially, or in time intervals.
Dependencies are inferred from the claim text.